Immunoassays are a valuable tool in many industries, ranging from human health to environmental monitoring because they can provide accurate measurements. Unfortunately, most immunoassay users are faced with a trade-off between sensitivity and specificity of laboratory Enzyme Linked Immunosorbent Assays (ELISAs) and the ease of use, speed and low cost of lateral flow immunoassays (LFAs) for point-of-care and point-of-need applications. Burst Diagnostics CaDI technology solves this problem by providing the performance of a laboratory ELISA with the simplicity of use of an LFA.

Burst Diagnostics is solving this problem. If you need a more sensitive point-of-care or point-of-need assay or want to transfer your laboratory assay to the field, contact us. Starting from your reagents and targets, we will work with you to develop a sensitive point-of-need assay that addresses your key market gaps.

• Custom development of sensitive point-of-need and point-of-care assays

• Proof-of-principle in as fast as six weeks

• Ability to manufacture tests in large quantities

Contact us today to discuss how Burst Diagnostics can help you solve your point-of-care and point-of-need assay requirements.